1. Home
  2. NCLH vs RGEN Comparison

NCLH vs RGEN Comparison

Compare NCLH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Norwegian Cruise Line Holdings Ltd.

NCLH

Norwegian Cruise Line Holdings Ltd.

HOLD

Current Price

$20.86

Market Cap

10.7B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$156.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCLH
RGEN
Founded
1966
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
NCLH
RGEN
Price
$20.86
$156.66
Analyst Decision
Buy
Buy
Analyst Count
18
10
Target Price
$28.89
$170.90
AVG Volume (30 Days)
15.3M
696.6K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
11.76
N/A
EPS
1.40
0.03
Revenue
$9,692,558,000.00
$707,890,000.00
Revenue This Year
$6.85
$17.84
Revenue Next Year
$10.76
$12.57
P/E Ratio
$14.93
$6,185.26
Revenue Growth
3.59
11.74
52 Week Low
$14.21
$102.97
52 Week High
$29.29
$182.52

Technical Indicators

Market Signals
Indicator
NCLH
RGEN
Relative Strength Index (RSI) 62.86 47.50
Support Level $18.51 $160.11
Resistance Level $19.23 $165.02
Average True Range (ATR) 0.63 4.97
MACD 0.42 -1.27
Stochastic Oscillator 86.83 7.12

Price Performance

Historical Comparison
NCLH
RGEN

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: